Search This Blog

Tuesday, August 6, 2019

Enanta Pharma EPS beats by $0.19, misses on revenue

Enanta Pharma (NASDAQ:ENTA): Q3 GAAP EPS of $0.33 beats by $0.19.
Revenue of $44.4M (-22.5% Y/Y) misses by $2.58M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.